Clinical Trial Update: Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of fexofenadine in patients with mild to moderate persistent asthma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fexofenadine (Allegra) (fexofenadine)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED